A new study by Stanford Medicine has cast doubt on the ability of Pfizer’s antiviral treatment Paxlovid to alleviate symptoms of long COVID. The research,…
A new study by Stanford Medicine has cast doubt on the ability of Pfizer’s antiviral treatment Paxlovid to alleviate symptoms of long COVID. The research,…